Vitamin D Supplementation as a Neoadjuvant for Photodynamic Therapy of Actinic Keratoses
Status:
Active, not recruiting
Trial end date:
2021-12-31
Target enrollment:
Participant gender:
Summary
This study is open to individuals with Actinic Keratoses (skin lesions that have the
potential to turn into skin cancer), who are receiving photodynamic therapy (PDT) as part of
their clinical care. The purpose of this study is to test and demonstrate that vitamin D
pre-treatment can enhance PDT efficacy in the treatment of Actinic Keratoses.
Participants will be asked to take vitamin D supplements prior to their standard of care PDT
treatment.
Participation in the research will last about 3-4 months.
Phase:
Phase 2
Details
Lead Sponsor:
Case Comprehensive Cancer Center
Treatments:
Cholecalciferol Ergocalciferols Vitamin D Vitamins